Managing Director at Optimax Access; Former Member of ERG (Evidence Review Group) at NICE; Head of Health Economics at Device Access
Speaker information:
He is a professional health economist located in the UK with more than 15 years of experience
e in the field of health technology assessment (HTA). He is one of the top 5 most referenced
scientists worldwide in the HTA sector. He used to work at NICE (The National Institute for
Health and Care Excellence) as a member of the Evidence Review Group (ERG), which was in
charge of assessing the health economic models that pharmaceutical companies submitted
to NICE. In different therapeutic fields (oncology, diabetes, cardiovascular diseases,
ophthalmology, etc.), He have created over 120 economic evaluation
models (costeffectiveness, costutility, cost consequence, and Budget Impact Analysis)
from scratch and published over 120 articles interviewed journals. He have such a great
commercial sense, extensive knowledge of health economics, and he quite self-motivated.
Dr. Mehdi Javanbakht will be presenting his speech on “Online Platform for health economics evaluation, a way to provide a strong infrastructure to inform decision-making process in health sector“
Experience
- Founder and Chief Executive Officer (CEO), Optimax Access
- Senior Health Economist at Newcastle University
- Senior Consultant, PAREXEL
- Research Fellow, University of Aberdeen
Education
IUMS University of Medical Sciences
Artificial intelligence, healthcare ,Health disinfection, Nursing, infection, Health society
Submit your abstract now: https://health.universeconferences.com/artificial-intelligence/
Don’t miss this chance Register now: https://health.universeconferences.com/registration/